Advertisement
<< Back To Article
Generic HIV Meds Could Save U.S. $1B a Year, But Risk Lowering Adherence

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

5 Comments

Shedonehimwrong

After almost 30 years of HIV your would think that congress and drug makers would insist on reliable low cost generic drugs for people with HIV...a lifesaving drug should cost 20K a year and upward. It always the same old excuses...doubt it will ever change...time for generics is NOW

January 23, 2013 Orlando

David

Speculation about the impact on adherence of 3 pills vs 1 is not helpful - we need the savings from generics. Empirical research is needed. My own experience is that it makes no difference. I went from Atripla when I was in the UK to the 3 pill combo when I moved to NZ (NZ public health system funds the individual pills but does not fund Atripla). My adherence has not changed one jot. Developing the habit of taking meds is what counts not how many pills.

January 23, 2013 Wellington, New Zealand

Tim

I know someone who had to go without meds because he was jobless. His cd4 count dropped below 50 before my state pulled it's head out of it's butt and started funding HIV. Can we stop talking about how good we have it "compared to the bad old days"? Death by AIDS is death by AIDS,regardless of the decade. The constant deference and hierarchy within HIV politics is ridiculous.

January 23, 2013

Michael

Phil, I think the resulting therapy could be two or three pills instead of the one pill... Very little trouble considering what guys in the 80s/early 90s had to do! When I hear guys now complain about one or two or three pills, I wanna slap 'em... We have it SO easy now compared to then.

January 22, 2013 NYC

Phil

I do not understand how saving on HIV Meds would lower adherance to taking the medications. I really need cheaper meds.

January 22, 2013 Panama City

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.